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The severe acute respiratory syndrome coronavirus (SARS-CoV) genome is predicted to encode 14 functional open reading
frames, leading to the expression of up to 30 structural and non-structural protein products. The functions of a large number of
viral ORFs are poorly understood or unknown. In order to gain more insight into functions and modes of action and interaction
of the different proteins, we cloned the viral ORFeome and performed a genome-wide analysis for intraviral protein
interactions and for intracellular localization. 900 pairwise interactions were tested by yeast-two-hybrid matrix analysis, and
more than 65 positive non-redundant interactions, including six self interactions, were identified. About 38% of interactions
were subsequently confirmed by CoIP in mammalian cells. Nsp2, nsp8 and ORF9b showed a wide range of interactions with
other viral proteins. Nsp8 interacts with replicase proteins nsp2, nsp5, nsp6, nsp7, nsp8, nsp9, nsp12, nsp13 and nsp14,
indicating a crucial role as a major player within the replication complex machinery. It was shown by others that nsp8 is
essential for viral replication in vitro, whereas nsp2 is not. We show that also accessory protein ORF9b does not play a pivotal
role for viral replication, as it can be deleted from the virus displaying normal plaque sizes and growth characteristics in Vero
cells. However, it can be expected to be important for the virus-host interplay and for pathogenicity, due to its large number of
interactions, by enhancing the global stability of the SARS proteome network, or play some unrealized role in regulating
protein-protein interactions. The interactions identified provide valuable material for future studies.
Citation: von Brunn A, Teepe C, Simpson JC, Pepperkok R, Friedel CC, et al (2007) Analysis of Intraviral Protein-Protein Interactions of the SARS
Coronavirus ORFeome. PLoS ONE 2(5): e459. doi:10.1371/journal.pone.0000459
INTRODUCTION
The observation of atypical pneumonias in the Chinese province
Guangdong in November 2002 led to the identification of the
severe acute respiratory syndrome (SARS). Within a few months,
the disease spread to a large number of countries and caused more
than 8,000 cases and almost 800 deaths. The causative pathogen
identified was shown to be a new human coronavirus designated
the SARS-CoV [1]. Tight intervention strategies limited the
further spread of the pathogen. Sequence analysis of the first
isolates of the newly identified SARS-CoV revealed characteristic
features typical of the known three coronavirus groups [2–4].
According to several phylogenetic analyses the virus is grouped
either a novel group IV or an early split-off of group II
coronaviruses [5,6].
The genome of the SARS-CoV consists of a positive-stranded
RNA of approximately 29,700 nt in length. The replicase genes
span the first two-thirds of the genome containing the two
overlapping ORF1a and ORF1b, which are connected by
a ribosomal frameshift. The two polyproteins expressed are
predicted to encode and to be cleaved by a papain-like proteinase
2 (PL-Pro = part of nsp3) and a 3C-like proteinase (3CL-
Pro= nsp5) to 16 mature replicase proteins [1,6]. They are well
conserved between SARS-CoV and other coronaviruses. It is
suggested that they are required for the synthesis of the full-length
genome and subgenomic RNA synthesis as well as for virus
replication [6,7]. Functions of the processed proteins include
a single-stranded RNA-binding protein (nsp9) an RNA-dependen-
dent RNA polymerase (RdRp=nsp12) as well as a non-canonical
RdRp (nsp8) synthesizing short primers for nsp12, a superfamily 1-
like helicase (HEL1=nsp13), and a uridylate-specific endoribo-
nuclease (NendoU=nsp15) [7–15]. Nsp3, nsp14, nsp16 are
thought to have ADP-ribose 19-phosphatase, 39-.59 exonuclease
and 29-O-ribose methyltransferase activities, respectively [6]. But
many of the functions of the nsps are still unknown. At their 59-
terminus the subgenomic mRNAs share a common leader sequence
encoded at the 59- end of the genome, which is joined to the
respective gene sequences at specific transcription regulatory
sequences. Their common 39- ends extend to the end of the genome.
The last third of the genome encodes the S, E, M and N
structural genes with the group-specific genes interspaced among
them. Former are encoded by mRNAs 2, 4, 5, and 9, latter by
transcripts 3, 6, 7, 8, and 9, respectively. These genes, ORF3a/b,
ORF6, ORF7a/b, ORF8a/b, and ORF9b are not found in other
coronaviruses and their functions with respect to replication and
pathogenesis are not well understood. There is evidence that some
of the accessory ORFs can be deleted individually or in
combination with almost no impact on in vitro growth, RNA
synthesis, or on in vivo virus replication in a murine model [16].
Also, the nsp2 replicase protein of murine hepatitis virus (MHV) and
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SARS-CoV is dispensable for virus replication in cell culture. Its
deletion results in attenuation of viral growth and RNA synthesis
[17]. There are reports that a number of MHV and SARS-CoV
replicase proteins colocalize and eventually interact in cytoplasmic
membrane bound complexes, in which viral RNA synthesis occurs
[18,19]. Direct interactions of nsp7 and nsp8 in a hexadecameric
supercomplex could be demonstrated by crystallography [20].
Interactions of the structural N and M proteins were demonstrated
by a mammalian two-hybrid system [21].
For the elucidation of molecular mechanisms during the course
of viral growth and propagation there is a need to systematically
examine possible interactions of all viral proteins. We therefore
cloned the SARS-CoV ORFeome by recombinatorial cloning
(GATEWAY technology) and performed a genome-wide analysis
for viral protein interactions by yeast-two-hybrid (Y2H) matrix
screen.
RESULTS
Generation of a SARS-CoV ORFeome
We have designed a set of nested PCR primers to amplify all viral
non-structural, structural and accessory ORFs at the predicted
protease cleavage sites or at the respective start and stop codons
(Table 1). For cloning reasons, nsp3 was subdivided into a N-
terminal (nsp3N, nt positions 2719–4431) and a C-terminal
(nsp3C, nt positions 4885–8484) fragment containing the ADP-
ribose-1’’monophosphatase domain and the Papain-like protein-
ase, respectively. An accessory ORF14 described only by Marra et
al. was also included [3]. Primers were designed such that they
contained gene-specific sequences for the amplification of the
respective ORFs. Overhanging sequences made them compatible
to the GatewayH recombinatorial cloning system allowing the
cloning into a so-called pDONR207 vector with the subsequent
subloning into the destination vectors pGADT7-DEST (prey) and
pGBKT7-DEST (bait).
Y2H screen of the individual SARS-CoV ORFs and
confirmation by CoIP
The Y2H bait and prey vectors pGADT7-DEST and pGBKT7-
DEST containing the SARS ORFs were transformed into the
haploid yeast strains AH109 and Y187, respectively, and mated
and grown under selective conditions on media lacking leucine,
tryptophane and histidine. All ORFs were tested pairwise against
each other and 900 individual interactions were tested in
quadruplicates. Interaction of the viral proteins was indicated by
colony growth on the selective plates. The result of the matrix
screen is shown in Figure 1. Positive interactions are indicated by
(black and patterned squares). Positive Y2H interactions were
validated by co-immunoprecipitation (CoIP) in mammalian 293
cells as a second interaction test (double-lined red squares). Of 65
interactions detected by Y2H 25 were corroborated by CoIP. Four
CoIPs were detected in both directions: non-structural proteins
nsp12 (RdRNAP) and nsp13 (C/H, NTPAse, dNTPAse, 59- to 39
RNA helicase, DNA Helicase, RNA 59- triphosphatase), nsp8 and
accessory protein ORF9b, nsp14 (C/H, 39- to 59 exoribonuclease)
and ORF9b, and accessory proteins ORF8a and ORF8b. Six of
the proteins, including nsp7, nsp8, nsp13, ‘‘E’’, ORF9b and
ORF14 interacted with themselves indicating the formation of
dimeric or multimeric complexes. Four of the self-interactions
including nsp8, ‘‘E’’, ORF9b and ORF14 self-interactions were
also found in the CoIP assay. Two non-structural proteins nsp2
and nsp8, and the accessory protein ORF9b showed a rather large
number of interactions (8, 14 and 15 interactions, respectively).
Table 1. SARS-CoV Orfs used for construction of the viral orfeome
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Protein Predicted AA No. AA Cloned nt Protein No. AA Cloned nt
Non-structural proteins: Structural proteins:
nsp1 M1-180G 180 265–804 S 1255 21492–25259
nsp2 A181-818G 638 805–2718 E 76 26117–26347
nsp3 A819-G2740 1922 2719–8484 M 221 26398–27063
nsp3N: (ADRP) A819-1389E 2719–4431
nsp3C: (PLP) E1541-2740G 4885–8484
nsp4 K2741-3240Q 500 8485–9984 N 422 28120–29388
nsp5: 3CLpro S3241-3546Q 306 9985–10902
nsp6 G3547-3836Q 290 10903–11772 Accessory proteins:
nsp7 S3837-Q3919 83 11773–12021 3a 274 25268–26092
nsp8 A3920-Q4117 198 12022–12615 3b 154 25689–26153
nsp9 N4118-Q4230 113 12616–12954 6 63 27074–27265
nsp10 A4231-Q4369 139 12955–13371 7a 122 27273–27641
nsp11 S4370-V4382 13 13372–13410 7b 44 27638–27772
nsp12(Pol) S4370-Q5301 932 13372–16166 8a 39 27779–27898
nsp13(Hel) A5302-Q5902 601 16167–17969 8b 84 27864–28118
nsp14(ExoN) A5903-Q6429 527 17970–19550 9b 98 28130–28426
nsp15(XendoU) S6430-Q6775 346 19551–20588 14 70 28583–28795
nsp16(29-O-MT) A6776-N7073 298 20589–21482
Products of ORFs 1a and 1ab with predicted processing positions are listed as non-structural proteins nsp1 through nsp16. Nucleotide positions used to clone the
individual SARS-CoV ORFs and the expected amino acid length are also given. Pol: RNA polymerase; Hel: C/H,NTPase,dNTPase, 59-to39RNA helicase and DNA helicase,
RNA 59triphosphatase; ExoN: 39-to-59 exoribo-nuclease, C/H; XendoU: Uridylate-specific enodribonuclease; 29-O-MT: 29-O-ribose methyltransferase. Nomenclature by
Snijder et al. 2003 and Thiel et al. 2003.
doi:10.1371/journal.pone.0000459.t001..
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Interactions of non-structural proteins
Six interactions of the non-structural proteins nsp2 could be
confirmed by CoIP including the non-structural proteins nsp3N,
nsp6, nsp8, nsp11 and nsp16 and ORF 3a, which only recently
had been described to be a novel structural protein [22,23].
Figure 2A shows IP and CoIP results with anti-HA and anti-c-myc
antibodies: 293 cells were transfected with HA-tagged nsp2 and c-
myc-tagged nsp2-, nsp3N-, nsp6- or nsp8. The lysates were split
into two and immunoprecipitated in the presence of protein G
with the anti- HA (left upper panel) or with the anti- c-myc (right
upper panel) antibody. The bound proteins were separated by
12.5% SDS-PAGE Western blot analysis. Expressed HA-tagged
proteins are indicated by stars and coprecipitated proteins by
arrows. Although the nature of the additional protein species with
higher molecular weight in the anti-HA WB of the anti-c-myc
CoIP is unclear, they might reflect a multimeric nsp2 band that is
not present in the other lanes, further supporting the nsp2-nsp2
interaction. But they could also be a result of post-translational
modification upon binding to other proteins. In the reciprocal
analysis (lower left and right panel) nsp2 proteins coprecipitated
with itself and with nsp3N.
The second-most connected protein of the replicase complex is
nsp8 (figure 2A, 2B). Of the 14 interacting proteins (nsp2, nsp5,
nsp6, nsp7, nsp8, nsp9, nsp12, nsp13, nsp14, E protein, ORF8,
ORF8a, ORF9b, ORF14) found in the Y2H system eight could be
confirmed by CoIP (nsp2, nsp7, nsp8, nsp9, nsp12, nsp13, nsp14,
E protein). Nsp 8 and nsp12 proteins interacted with ORF9b and
nsp13, respectively, in both directions in the Y2H. This was also
the case for the interaction between nsp14 and ORF9b, which
could also be confirmed by CoIP.
Interactions of structural proteins
Of the ‘‘classical’’ structural proteins S, E, M and N, only the E
protein showed a number of interactions with the non-structural
Figure 1. Analysis of SARS-Co viral protein interactions by Y2H matrix screen and CoIP in mammalian cells. Y2H matrix screen was performed by
mating S. cerevisiae strains AH109 and Y187 containing prey and bait vectors with the respective SARS-CoV ORFs on selective media. All ORFs were
tested against each other. Positive interactions in yeast (black and grey squares) were retested by CoIP in mammalian cells (293cells) using anti- HA
(preys) and anti-c-myc (baits) antibodies. Interactions tested positive in 293 cells by CoIP are encircled in red.
doi:10.1371/journal.pone.0000459.g001
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proteins nsp1, nsp8, nsp11, as well as with the accessory proteins
ORF3b, ORF7b and ORF9b. Interestingly, M and S reacted with
the only recently described accessory structural proteins ORF 3a
and ORF7a [22,24]. Self-interaction of the E protein was seen in
both assays. The interaction between the structural proteins N and
M, which has been described in two recent reports [21,25], was
found positive by CoIP only.
Interactions of accessory proteins
The most dominant interactor of the accessory proteins was the
ORF9b. Of the 16 ORF9b Y2H interactions detected, four could
be confirmed by CoIP (Figure S1). 10 of the non-structural and
five of the other accessory proteins showed interactions with other
proteins. Self interactions were seen for ORF9b and ORF14.
These could be confirmed by CoIP in both directions as well as the
reactivity of ORF7b with the two E and ORF 6 proteins. ORF 8a
and ORF 8b were also reactive in both directions in the Y2H
system.
Deletion of ORF9b from SARS-CoV
The dominant interactor proteins nsp2 [17] and nsp8 (Deming et
al., submitted) are dispensable or essential for viral replication in
vitro, respectively. To determine the importance of the dominant
interactor ORF9b accessory protein for viral growth a deletion
mutant was made by synthesizing a DNA fragment that included
changes that ablate each of the ORF9b ATG start sites while
maintaining the primary sequence of the N protein (Figure 3A).
The recombinant virus had normal plaque sizes and grew like
wildtype virus in Vero cells after infection at a MOI of 0.1 PFU/
cell (Figure 3B). Thus, deletion of ORF9b is not lethal.
Bioinformatical analysis
Comparison of SARS-CoV and herpesvirus intraviral
protein interaction screens
Y2H matrix and CoIP interaction screens of the present study
were performed similarly as in our recently published study on
herpesviral protein networks describing intra-viral protein inter-
actions in Kaposi sarcoma-associated herpesvirus (KSHV) and
Varicella-Zoster virus (VZV) [26]. Table 2 shows the comparison
of network parameters of SARS to KSHV as well as other cellular
protein interaction networks. The average degree and character-
istic path length are slightly smaller than in the KSHV network
and significantly smaller than in the cellular networks due to
smaller network size. The fraction of pairwise interactions
confirmed among those tested is higher in the SARS network
with 65 out of ,450 possible non-redundant pairwise interactions
( = 14.4%) than in the KSHV network with 123 out of ,4050
possible interactions ( = 3%). Furthermore, the clustering co-
efficient is significantly higher than in all of the networks analyzed.
When comparing against random networks of the same size, we
found that the clustering coefficient is approximately as high as
expected at random given the degree distribution. Interestingly for
the KSHV network it is actually smaller, whereas for the cellular
networks it is much higher.
Figure 2. CoIPs of non-structural proteins nsp2 and nsp8. 293 cells were infected with vaccinia virus vTF-7 and subsequently co-transfected with
HA- and c-myc- tagged plasmids carrying the respective SARS-CoV ORFs. After 20 hours half of the cell lysate was immunoprecipitated with anti-HA,
the other half with anti- c-myc antibody. Bound proteins were subjected twice to 12,5% SDS-PAGE and Western Blot transfer, and probed cross-wise
with the two antibodies. Co-precipitated proteins are indicated in the right panels. HA and c-myc tags are expressed as N-terminal fusions with the
corresponding SARS-CoV ORF in plasmids pGADT7 and pGBKT7, respectively. Stars indicate expression products by IP, arrows by CoIP.
doi:10.1371/journal.pone.0000459.g002
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SARS-CoV-host interaction network
Known virus-host and intraviral interactions of SARS proteins
were identified by a literature screen (see Tables S1 and S2). Based
on ten known SARS-host interactions as well as two interactions
predicted from homologous proteins, the viral network was
connected to the human network assembled from large-scale
Y2H screens [27,28], ortholog predictions [29] and literature
mining ((Ref-HPRD) and [27]). The SARS-CoV-host interaction
network is shown in Figure 4. Human proteins are included which
are distant from the SARS-CoV proteins by at most two or three
interactions as well as the interactions between these proteins. On
the basis of the small number of known virus-host interactions the
intraviral SARS-CoV network is separated from the bulk of the
human interactome. Proteins targeted by SARS either directly or
via other proteins are involved in various molecular functions and
pathways such as apoptosis, cell communication and signalling
pathways. The literature screen for intraviral SARS interactions
identified 23 interactions. 3 of these (13%) were also determined
by the Y2H screen.
Immunofluorescence localization of SARS-CoV ORFs
To systematically study the subcellular localization of viral proteins
within eukaryotic HeLa cells the SARS-CoV ORFs were
transfected in eukaryotic vectors with either N- or C- terminal
Flag tags and detected with an anti-Flag antibody. Since artificial
tagging of proteins often leads to an aberrant expression in cellular
compartments, we tagged the SARS-CoV protein on both the N-
and C- terminus and only considered the cellular localization
correct if consistent with both tags [30]. Some of the proteins were
not expressed if tagged either N- or C- terminally (see Figure S2),
and some were not expressed at all, and were not included in the
analysis.
Figure 3. Deletion of ORF9b from SARS-CoV. DNA sequences of wild-type and of modified ATG start codons of ORF9b are given on the left. The
primary sequence of the N protein was maintained. Viral growth curves are shown on the right.
doi:10.1371/journal.pone.0000459.g003
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Table 2. Comparison of network parameters of viral and cellular protein interaction networks
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Network parameters SARS-CoV Y2H KSHV S. cerevisiae (DIP) H. sapiens
No.Nodes 31 50 4959 10470
No. Edges (including self-interactions) 65 123 17511 45104
Average Degree 4.19 4.92 7.06 8.62
Characteristic path length 2.43 2.84 4.15 4.29
Diameter 5 7 11 14
Clustering coefficient 0.41 0.146 0.124 0.143
Enrichment over ER 2.92 1.56 87.12 174.3
Enrichment over ES 1.00 0.75 7.02 12.44
The table shows network parameters for two viral and two cellular protein interaction networks. The SARS network contains 65 interactions between 31 nodes with 6 of
those interactions being self-interactions. For comparison purposes, network parameters are also shown for KSHV [26], S. cerevisiae and H. sapiens. Interactions for the
cellular networks were derived from the following sources: S. cerevisiae from DIP (the Database of Interacting Proteins) [45], the yeast two-hybrid interactions of H.
sapiens from the studies of Stelzl et al. [28] and literature interactions from Rual et al.[27], predicted human interactions (core) from Lehner and Fraser [29] and
interactions taken from the HPRD (human protein reference database) [46]. Parameters shown include the number of nodes and edges in the networks, the average
degree, characteristic path length (average shortest path), diameter (maximum shortest path), clustering coefficient and for the clustering coefficient enrichment values
compared to appropriate random networks (ER and ES). Both types of random networks contain the same number of nodes and edges as the original network. ER
networks [47] are created by connecting edges randomly, whereas ES networks are created by an edge swapping strategy which preserves the degree distribution (see
[26,48]). Enrichment values are calculated over the theoretical clustering coefficients of ER networks and the average clustering coefficient of 1000 randomized ES
networks.
doi:10.1371/journal.pone.0000459.t002..
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Figure 4. SARS-CoV-host interaction network. Viral interactions are based on the experimental Y2H findings. Human interactions were taken from
the combined human interaction network described in Table 2. Interactions between SARS and human proteins were gathered from the literature
and are listed in Supplemental Table 1. The figure shows the SARS interaction network (A) and proteins and interactions which are separated from the
SARS network by no more than 2 (B) and 3 (C) interactions, respectively. SARS-CoV proteins are depicted in dark red, their direct targets (distance 1) in
light red, neighbours of the direct targets (distance 2) in orange and neighbours of the latter (distance 3) in yellow.
doi:10.1371/journal.pone.0000459.g004
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ORF3a, ORF7a and M were detected in the Golgi, ORF3b in
the nucleus, ORF6, ORF7b, nsp3N and nsp16 in the ER
(Figure 5). ORF8b and ORF14 showed a vesicular staining, and
nsp2 was found both in cytoplasm as well as in the nucleus. Orf3a
and M were found to be interacting by Y2H, and were both
detected in the Golgi. Similarly, ORF6 and ORF7b were both
found in the ER.
DISCUSSION
In this study we report the cloning of the complete ORFeome of
SARS-CoV and the results of a matrix-based yeast two-hybrid
screen of pairwise viral protein-protein interactions. From
a number of recent structural studies it is clear that during the
viral life cycle large replication complexes are formed, which
involve a large number of viral proteins [31]. SARS-CoV is
a representative of the Coronaviridae, the largest RNA viruses
known (27 to 32 kb, plus-stranded). SARS-CoV expresses at least
16 non-structural replicase proteins which are cleaved co- and
post-translationally from two precursor polyproteins by two viral
proteinases, four structural proteins and a set of eight accessory
proteins specific for the individual virus groups [6]. Since the
polypeptide processing sites of non-structural proteins are well
defined, we chose the strategy to subclone all individual ORFs
predicted, and not to use the precursor polyproteins. Using this
approach we expected to avoid problems in the expression, folding
or targeting of the polypeptides due to incorrect processing. Such
problems had been reported for yeast two-hybrid assays performed
with the plus-stranded RNA viruses Hepatitis C virus [32] and
wheat streak mosaic virus (WSMV) [33], where interactions had
been observed only when random fragments, not mature proteins
were used. But there are also reports on potato virus A (PVA) and
pea seed-borne mosaic virus (PsbMV), which belong to the
potyvirus (+) strand RNA virus family similar to WSMV [34], as
well as on a subset of poliovirus proteins [35], where interactions
have been detected among cloned mature proteins.
In our screen approximately 14% of the 450 possible non-
redundant protein interactions tested were positive and approx-
imately 38% of which were confirmed by CoIP. This result is in
the same order of magnitude as the outcome of similar Y2H
matrix screens in KSHV and VZV, indicating that this approach
can also be applied for plus-strand RNA viruses. The low numbers
of Y2H interactions detected in two directions are a common
phenomenon in Y2H assays and are probably due to steric
constraints of either bait or prey fusion proteins.
Coronavirus replication complexes consist of intricate macro-
molecular structures in which many of the non-structural replicase
proteins are involved. One of the most interesting interactor
proteins found in our study is nsp8, which interacts with replicase
proteins nsp2, nsp5, nsp6, nsp7, nsp8, nsp9, nsp12, nsp13, nsp14.
The importance of this protein is supported by recently reported
crystallization studies, which described the multimeric association
of various of the non-strucutural proteins. Nsp 8 seems to be one of
Figure 5. Subcellular localization analysis of SARS-CoV ORFs. Expression plasmids containing N- and C- terminally FLAG -tagged ORFs were
transfected into Hela cells and analysed after 24 hours with an anti- FLAG antibody for expression and localization of their products.
doi:10.1371/journal.pone.0000459.g005
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the proteins involved in these complexes. Nsp8 deletion or
irreversible fusion to nsp7 or nsp 9 by mutagenesis of the
corresponding cleavage site results in a lethal phenotype support-
ing the idea that nsp8 is absolutely essential for virus replication
(Deming et al., submitted). Evidence has been presented for
interaction with nsp9, a ssRNA-binding protein, by analytical
ultracentrifugation experiments and by a decrease of the disorder
of the nsp8 N-terminal region after the addition of nsp9 [36].
Furthermore, a hexadecameric nsp7-nsp8 supercomplex was
described which was suggested to encircle RNA where it may
serve as a general processivity factor for the RNA-dependent RNA
Polymerase (RdRp) nsp12 (19). A very recent report described
nsp8 as a second RdRp of SARS-CoV. It was shown to initiate the
synthesis of complementary oligonucleotides of ,6 residues in
a low fidelity reaction which eventually might serve as primers for
the primer-dependent nsp12 RdRp [15]. For MHV it was shown
that RdRp co-immunoprecipitates with nsp8, nsp9, nsp5 and the
helicase nsp13 [37], and that it also colocalizes with nsp7, nsp9
and nsp10 [18,37]. Thus, the nsp8 interactions found by us are
confirmed by a number of different studies and it seems to play an
important role in the viral replication complex.
In this manuscript, we demonstrate interactions between RdRp
(nsp12) and nsp8, and with the helicase nsp13 in both directions of
the Y2H screen. It is likely that the RdRp interacts with more nsps
than were found, but these interactions may require mediator
proteins like nsp8.
Nsp2 interacted with seven other nsps including nsp8 and with
one of the newly described structural proteins ORF3a. As shown
by CoIP, it also self interacts to a dimeric or multimeric complex.
The relatively large number of interactions might imply a crucial
role of nsp2 in the viral life cycle. However, it was shown by
deletion mutants of SARS-CoV and MHV that neither the
encoding genomic RNA sequences nor the nsp2 proteins are
necessary for the generation of infectious viruses in cell culture
[17]. Since these viruses displayed slightly reduced phenotypes in
growth, RNA synthesis but not protein processing, it was
speculated that nsp2 might play a role in global RNA synthesis,
and possibly in virus-cell interactions or viral pathogenesis. The
reported subcellular localization of individually expressed nsp2 in
delayed brain tumor (DBT) cells [17] is similar to the diffuse
cytoplasmic and nuclear immunofluorescence staining pattern found
with our N- or C- terminally tagged nsp2 proteins. Thus, the
exogenously expressed nsp2 does not target specific membranes in
the absence of infection. However, after coinfection with a MHV
mutant virus lacking nsp2, the protein expressed in trans was reported
to be recruited into distinct viral replication complexes. This
relocalization of nsp2 to small vesicular foci in the cytoplasm was
also confirmed in SARS-CoV-infected Vero cells by immunofluo-
rescence staining with anti-nsp2 antibodies [19].
In our study, only few interactions were found for the structural
proteins, which might be biased by transmembrane sequences
preventing the transfer of expressed prey (containing the GAL4
activating domain) and/or bait (containing the GAL4 DNA-
binding domain) fusion proteins to the nucleus of the yeast cell
where protein-protein interaction leads to transcription. Only the
E and ORF3a proteins showed a number of associations whose
relevance is unclear. Interactions of ORF3a –M and ORF7a-S fit
to the recent finding that the two accessory proteins display
structural functions as has been described [24,38].
For the group-specific accessory proteins it has recently been
shown that deletion of five of the eight ORFs (ORFs 3a, ORF3b,
ORF6, ORF7a and ORF7b) alone or in combination did not
influence dramatically the level of RNA or the replication
efficiency in vitro or in an in vivo mouse model [16]. The most
interesting accessory protein with respect to interactions in our
study turned out to be ORF9b. Y2H interactions with nsp8 and
nsp14 were found bi-directionally and the self-interaction could
also be confirmed by CoIP. Latter result is confirmed by recent
structure data [39]. The ORF9b protein, which is encoded within
the nucleocapsid gene, is an intertwined dimer with an
amphipathic outer surface and a long hydrophobic lipid binding
tunnel. This suggests that ORF9b is targeted to ER-Golgi
compartments via an unusual anchoring mechanism and acts as
an accessory protein during virion assembly. Although most of the
accessory proteins do not seem to play pivotal roles in viral
replication, they might still be important for the virus-host
interplay and for pathogenicity. Currently, there is no reasonable
explanation for the large number of interactions found for ORF9b
by the Y2H screen. As deletion of ORF9b does not seriously
reduce virus replication in vitro consistent with a luxury function,
the 9b protein may function to enhance the global stability of the
SARS proteome network and play some unrealized role in
regulating virus-host protein-protein interactions. It thus might be
more important for enhancing in vivo virulence.
Immunofluorescence localization of Flag-tagged viral proteins
corresponded in most cases to published data on SARS-CoV and
other coronaviruses. We found nsp2 proteins in the cytoplasm and
to some extent in the nucleus which is in accordance with anti-
nsp2 antibody stainings of stably DBT-nsp2 (MHV) expressing
cells [17]. Many of the non-structural proteins are involved in the
replication of the virus and locate to virus-induced cytoplasmic
double-membrane vesicular complexes as the sites of viral
replication. It is therefore important to take into account that
the localization patterns of nsps might be quite different when
expressed individually in cells as compared to the situation of viral
infection where various viral proteins might help to recruit each
other to the sites of active replication.
Accessory protein 3a, for which a number of effects on cellular
functions were described [40], we located in our Flag-tagged
versions to the Golgi complex as Yuan et al. [41] observed using
EGFP-tagged constructs. As a structural protein ORF3a interacts
with the M protein [23] which was also clearly found in the Golgi
as Flag fusion proteins. The nuclear localization of ORF3b is also
reasonable because it induces cell cycle arrest at the G0/G1 phase
and apoptosis [42]. Proteins ORF6 and ORF7b, interacting in
Y2H and CoIP, were both found in the ER. To our knowledge
this localization has not been described for ORF7b before. Not
much is known about ORF9b other than it is expressed in infected
cells [43] and that antibodies to it are found in infected patients
[44]. As opposed to Meier et al. [39], who located ORF9b to
intracellular vesicular structures (293T cells), we found it to be
diffusely distributed within cytoplasm and nucleus (HeLa cells).
Analysis of network statistics showed that despite high clustering
coefficients the SARS interaction network is not higher clustered
than expected at random. It, thus, appears as a single module such
as the KSHV network and is not subdivided into separate
functional modules as cellular networks. Based on currently known
and predicted host-virus interactions, a joint virus-human network
was derived in which the viral part of the network appears to be
separated from the main host network. In this respect, the SARS
network differs from the KSHV viral network which is in-
corporated into the host interactome. However, this may be due to
the small number of virus-host interactions identified so far for
SARS. Indeed for KSHV, the predicted virus-host network was
based on about twice as many interactions to the host. To better
understand the role of the intraviral protein interactions it is
necessary to gain more knowledge on the SARS-CoV with it’s host
during infection.
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We certainly missed a considerable number of intraviral protein
interactions in our Y2H screen as can be seen for M-N and nsp2-
nsp2, nsp5-nsp5 self-interactions, which we could only detect by
CoIP. Although, it is generally acknowledged and certainly has to
be taken into account that Y2H assays are error-prone by
producing false positives and false negative results, we identified
a large number of interactions which have not been reported
previously and which could be confirmed biochemically. These
interactions will be of great help for further studies which are
aiming at the elucidation of SARS-CoV replication and patho-
genesis. Future experiments with the mutant viruses lacking nsp2,
nsp8 or ORF9b will show the relevance of the interactions
detected for virus replication, growth and pathogenicity in vitro and
in vivo model systems.
MATERIALS AND METHODS
Experimental Procedures
Viral nucleic acids
SARS-CoV orfs were derived from subcloned cDNAs described
by Yount et al. [16] and Thiel et al.[7]. ORFs were amplified by
nested polymerase chain reaction (PCR) using plasmids pTOPO
XL containing fragments A (nt 1–4436) and B (nt4344–8712),
pSMART containing fragments C (8695–12070), D (12055–18924),
E (18907–24051) and F (24030–29736) as well as plasmids pMal-
ScoV-Mpro 5 (nsp5), pMal-ScoV-nsp8, pET-ScoV-POL 8 (nsp12),
pMal-SHEL-nsp13, pET-ScoV-ExoN 3 (nsp14), pMal-ScoV-nsp15-
7, pET-ScoV-MTR 12 (nsp16)and pBS-SARSCoV-S30.
Strategy for Recombinatorial Cloning of the SARS-
CoV ORFs
The nucleotide sequences of SARS-CoV Urbani (Genbank
Accession AY278741), Frankfurt (Genbank Accession
AY291315) and TOR2 (Genbank Accession NC_004718) isolates
were used to design primers for subcloning of all putative ORFs
and making them compatible to GatewayH recombinatorial
cloning system (Invitrogen). Nested PCRs were performed
with two separate sets of primers. For the first PCR internal
forward (AAAAAGCAGGCTCCGCCATGN14–27) and reverse
(AGAAAGCTGGGTCn13–20) primers containing the internal
attB1 and attB2 recombination sites were used. The gene-specific
59 forward sequence (N) introduced an AUG start codon prior to
the predicted protease cleavage sites with further 14–27 nucleo-
tides downstream, while the 39 reverse sequence (n) matched 13–
20 nucleotides. There was no stop codon introduced at the
specific ends of the predicted cleavage sites in order to allow
the C- terminal inframe fusion of tag sequences. The second
PCR was performed using forward (59-GGGGACAAGTT-
TGTACAAAAAAGCAGGCT-39) and reverse (59-GGGGAC-
CACTTTGTACA AGAAAGCTGGGT-39) primers which in-
cluded the external parts of the attB1 and attB2 recombination
sites. For the putative peptide nsp11 two oligos were synthesized
as the coding (59-AAAAAGCAGGCTCCGCCATGTCTGCGG
ATGCATCAACGTTTTTAAACGGGTTTGCGGTGGACC-
CAGCTTTCT-39) and non-coding (59-AGAAAGCTGGG-
TCCACCGCAAACCCGTTTAAAAACGTTGATGCATCCG
CAGACATGGCGGAGCCTGCTTTTT-39) strands. Primers
for ORFs N and S were designed such that the complete attB1
and attB2 sites were added to the gene specific sequences.
PCR conditions were 20 mM of dNTPs, 0,2–0,4 mM forward
and revers primers, 20 ng of template and 1 U of Long Expand
Taq Polymerase Enzyme (Roche Diagnostics GmbH). Depending
on size and nucleotide composition of the amplificates two
standard conditions were used for amplification. Protocol 1:
94uC for 5 min/30 cycles: 94uC for 90 sec, 52uC for 90 sec, 68uC
for 210 sec/72uC for 7 min/4uC ‘. Protocol 2 (touch down):
94uC for 4 min/10 cycles: 94uC for 30 sec, 55uC (lowered by 1
degree per cycle) for 30 sec, 72uC for 90 sec/30 cycles: 94uC for
30 sec, 50uC for 30 sec, 72uC for 90 sec/72uC for 7 min/4uC ‘.
PCR fragments were separated by Agarose gel electrophoresis and
purified utilizing Nucleospin Extraction Kits (Macherey& Nagel).
The resulting PCR-fragments, flanked by complete attB1 and attB2
sites, were cloned by GatewayH recombinatorial cloning into the
entry vectors pDONR207 or pDONR221 (Invitrogen) via the BP
Clonase reaction as described by the manufacturer (Invitrogen). The
overlaps of the vector and SARS-CoV-ORF sequences were
confirmed by DNA sequencing using the Big Dye Terminator kit
(Perkin Elmer) on a 377 DNA Sequencer, a 310 Genetic Analyser
(both Applied Biosystems) or the Genome Lab DTCS-Quick Start
Kit on the CEQTM 8800 Sequencer (Beckman Coulter).
Two eukaryotic destination vectors were constructed allowing
the inframe fusion of a HIS-Flag tag to the N-terminus and of
a Flag-HIS tag to the C-terminus of a the viral ORFs. For the N-
terminal tag a DNA oligo adaptor molecule was synthesized
(coding strand: 59-TTAGTCAAGCTTGAAGGAGATAGAGC-
CACCATGGCACACCATCACCATCACCATGACTACAAG-
GACGACGATGACAAGGCGATATCTTAATCTAGATGAT-
A-39) and sub-cloned via Hind III and XbaI restricition sites into
plasmid pCR3. The C-terminal oligo adaptor molecule (coding
strand: 59-TTTATATGATATCGACTACAAGGACGACGATGA
CAAGGCACACCATCACCATCACCATTAACTCGAGATT-
AATA-39) was subcloned via EcoRV and XhoI into pCR3.
Both plasmids were converted to destination vectors by ligating
an EcoRV – EcoRV DNA fragment, containing the GATE-
WAYH conversion cassette reading frame B (rfB cassette) into
their individual EcoRV sites. In the 59- and 39- tag vectors an
inframe stop codon was introduced immediately after the
EcoRV site or after the HIS tag sequence, respectively. The
Y2H destination vectors pGBKT7-DEST (bait) and pGADT7-
DEST (prey) were derived from pGBKT7 and pGADT7
(Clontech) by introducing a GATEWAYH rfB conversion
cassette into the SmaI sites as described recently (23). Into
these vectors the SARS-CoV ORFs were transferred from the
donor plasmids via LR reaction. Clones were checked by
restriction enzyme analysis using EcoRV for the HIS-/Flag tag
vectors and EcoRI and BamHI (NEB) for the yeast vectors.
Yeast-two-hybrid screen
The haploid Saccharomyces cerevisiae strains AH109 (MATa, trp1–
901 m, leu2-3, 112, ura3-52, his3-200, gal4D, gal80D, LYS::GA-
L1UAS-GAL1TATA-HIS3, MEL1 GAL2UAS-GAL2TATA-ADE2,
URA3::MEL1UAS-MEL1TATA-lacZ) and Y187 ( MATa, his3-
200, trp1-901, ade2-101, ura3-52, leu2-3, 112, gal4D, met,
gal80D, URA3::GAL1UAS-GAL1TATA-lacZ, MEL1) were chosen
for the yeast-two hybrid assay. AH109 and Y187 were
transformed using 1 mg of prey (pDEST-GADT7) or bait vector
(pDEST-GBKT7), respectively. Yeast cells were incubated for 1 h
in 750 ml PEG/Bicine solution (40% PEG 1000, 200 mM Bicine
pH 8.35) at 30uC, followed by 5 min at 45uC. Cells were pelleted
and resupended in 1 ml NP-buffer (0.15 M NaCl, 10 mM Bicine
pH 8.35), pelleted a second time and resuspended in 200 ml NP-
buffer and plated on to SD medium (+2% agar) lacking either
leucine (prey) or tryptophane (bait). Colonies were visible after 2–
3 days. The yeast strains AH109 and Y187 containing proteins in
prey and bait were arrayed in a 96-deep-well plates with SD liquid
media lacking leu or trp according to the interactions to be tested.
The liquid cultures were transferred on to SD medium plates
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lacking leu or trp using a 384-pin replica tool (Nunc). Colonies
were grown for 2 days at 30uC and used directly for mating on
YPD medium plates. Each mating was performed in quadrupli-
cates, and after 2 days at 30uC the colonies were stamped onto SD
medium (–Leu–Trp) plates. The interactions were assessed by
transfer to SD–Leu–Trp–His plates, and interactions considered
positive if at least three out of four possible colonies grew. Viral
proteins acting as self-activating baits were analyzed on increasing
amounts of +3 mM 3-Amino-1,2,4-triazole (3AT, Sigma) (3 mM,
10 mM, 50 mM and 100 mM), and excluded from the results if no
clear positive interactions could be determined.
Co-immunoprecipitation
293 cells were infected with recombinant vaccinia virus vTF-7
expressing the T7 RNA polymerase (NIH AIDS repository) at
a MOI of 10 in DMEM/1% FCS. One hour post infection, virus-
containing medium was removed and substituted by DMEM/1%
FCS. Ten micrograms (per dish) of the respective pGBKT7-
SARS-CoV-ORF and pGADT7- SARS-CoV-ORF plasmids were
then transfected into two 10 cm dishes of 293 cells using the
calcium phosphate method. After 20 to 24 h, cells were lysed by
incubation in NP-40 lysis-buffer (1% NP-40, 140 mM NaCl,
5 mM MgCl2, 20 mM Tris pH 7.6, 1 mM PMSF, one tablet of
Complete protease inhibtor cocktail (Roche) per 50 ml on ice for
30 min. Lysates were centrifuged at 20.5006 g for 10 min and
precleared using 50 ml preequilibrated protein G-sepharose
(Amersham Pharmacia). Lysates were precipitated using either
5 ml (200 mg/ml) mouse monoclonal anti-myc (Santa Cruz
Biotechnology) or 10 ml (100 mg/ml) rat monoclonal anti-HA
(Roche Diagnostics GmBH) antibodies in the presence of 50 ml
protein G Sepharose beads and incubated ON at 4uC by overhead
rotation. The beads were washed 3 times in ice-cold NP-40 buffer
and resuspended in 26SDS protein sample buffer. Precipitates were
separated by SDS-PAGE using 12.5% or 15% polyacrylamide gels.
Proteins were transferred to nitrocellulose (Schleicher & Schuell)
membranes in Western blot chambers ON at 4uC. Filters were
blocked with 5% milk powder in TBST (50 mM Tris, pH7.6,
150 mM NaCl, 0,05% Tween-20) for 1 h. They were then
incubated with the anti-myc and anti-HA antibodies at dilutions of
1:1000 ON at 4uC. Filters were washed three times for 10 min with
TBST. Incubation with the secondary, peroxidase-conjugated anti-
mouse IgG or anti-rat IgG (1:3000 each) antibodies (Jackson) was
carried out for two to three hours. After three further washing steps
filters were developed using the ECLTM Western Blotting Detection
Kit (Amersham Biosciences). The CoIP was scored positive if
a coprecipitate was detected in at least one direction.
Recombinant virus
Recombinant SARS-CoV technology was done as described by
Yount et al. [16]. The sequence of the mutated SARS-CoV
ORF9b knockout (icSARSDORF9b) was confirmed by sequencing
cDNA isolated from recombinant virus.
Immunofluorescence
Subcellular localization analysis of ORFs was carried out in HeLa
cells (ATCC CCL-2). Cells were transfected with the plasmids
using FuGENE6 (Roche) according to the manufacturer’s
instructions, for a total of 24 h. Cells were then fixed in ice cold
methanol prior to processing for immunofluorescence. Primary
mouse anti-FLAG (M2) (Sigma) and anti-mouse-Alexa488-conju-
gated secondary antibodies (Molecular Probes) were used to detect
transfected cells, and coverslips were mounted in Mowiol. Images
were acquired on a Zeiss Axiovert 200 microscope with a 636/1.4
NA oil objective and standard filter sets.
SUPPORTING INFORMATION
Figure S1 CoIPs of accessory proteins. 293 cells were infected
with vaccinia virus vTF-7 and subsequently co-transfected with
HA- and c-myc- tagged plasmids carrying the respective SARS-
CoV ORFs. After 20 hours half of the cell lysates was
immunoprecipitated with anti- c-myc, the other half with anti-
HA antibody (left panel). Bound proteins were subjected twice to
15% SDS-PAGE and Western Blot transfer, and probed cross-
wise with the two antibodies. Co-precipitated proteins are
indicated in the right panel. HA and c-myc tags are are expressed
as N-terminal fusions with the corresponding SARS-CoV ORF in
plasmids pGADT7 and pGBKT7, respectively.
Found at: doi:10.1371/journal.pone.0000459.s001 (0.20 MB TIF)
Figure S2 Subcellular localization analysis of SARS-CoV ORFs.
Expression plasmids containing N- or C- terminally FLAG -tagged
ORFs were transfected into Hela cells and analysed after 24 hours
with an anti-Flag antibody for expression and localization of their
products. For these ORFs either the N- or the C- terminally
FLAG-tagged ORF was detected.
Found at: doi:10.1371/journal.pone.0000459.s002 (0.21 MB TIF)
Table S1 Virus-host interactions from literature screen. The
table shows previously published interactions between SARS
proteins and their human targets as well as two interactions which
were predicted for SARS from interactions between homologous
proteins. Literature interactions were determined by manually
screening Medline-abstracts on SARS and related coronaviruses.
Found at: doi:10.1371/journal.pone.0000459.s003 (0.03 MB
DOC)
Table S2 Virus-virus interactions from literature screen. The
table shows previously published interactions among SARS
proteins. Interactions which were confirmed by our yeast two-
hybrid screen are marked in red. As for the virus-host interactions,
literature interactions were determined by manually screening
Medline-abstracts on SARS and related coronaviruses.
Found at: doi:10.1371/journal.pone.0000459.s004 (0.04 MB
DOC)
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